Boron-based Drug Design for Cancer Therapy

1 Results Selective inhibition of protein tyrosine kinases is gaining importance as an effective therapeutic approach for the treatment of a wide range of human cancers.The epidermal growth factor receptor (EGFR) protein tyrosine kinase is one of the important kinases that play a fundamental role in cell growth signal pathways.We focused on the 4-anilinoquinazoline framework,which is observed in both compounds as a common structure.A boron atom has a vacant orbital and interconverts with ease between th...     

盐酸溶液中乌鲁托品对钢的缓蚀性能

用电化学阻抗谱(EIS)和开路电位测量法(OCPM)研究了在1 mol·L-1盐酸溶液中乌鲁托品(UP)与45#钢的界面吸附及缓蚀行为.EIS表明:随着缓蚀剂UP浓度的增大,吸附膜逐渐形成,电荷传递电阻增大.在缓蚀剂浓度为0.01 mol·L-1时,缓蚀效率出现最大值;大于该浓度时,缓蚀效率下降.OCPM表明:加缓蚀剂UP前后体系自腐蚀电位的改变与温度的倒数呈线性关系.UP对阳极过程有抑制作用,是阳极型缓蚀剂;吸附热为-35 kJ/mol,吸附形式为物理吸附.     

人LDHA原核表达、纯化及体外抑制剂筛选模型的建立

在多数肿瘤细胞中高度表达的乳酸脱氢酶A(LDHA)与肿瘤的发生、发展和预后密切相关,筛选LDHA小分子抑制剂可提供一种富有潜力的靶向抗肿瘤策略.本研究以pET-28a为载体,构建了人LDHA表达质粒并于大肠杆菌BL21(DE3)中稳定表达,产量达到2.65mg/L.基于LDHA的催化反应建立了以丙酮酸钠和还原型烟酰胺腺嘌呤二核甘酸(NADH)为底物的筛选模型.实验结果表明:模型的LDHA最适质量浓度为60ng/mL,以质量分数0.25%草酸铵为阳性对照,筛选模型的Z因子为0.812.至此,本研究建立了LDHA抑制剂体外生化筛选模型,其成本低、可操作性强,符合高通量筛选要求,为发现新颖的LDHA抑制剂奠定了基础.     

A time-saving method to assess the efficiency of corrosion inhibitors by electro osmosis

The corrosion inhibitor is one of the most important technologies to enhance the durability of steel-reinforced concrete. A kind of time-saving method was developed to assess the inhibitor efficiency by using a 32 V electric field to accelerate chloride ion migration in concrete. Potentiodynamic polarization scanning test was used to evaluate the corrosion states. The comprehensive efficiency of an inhibitor should be assessed in two aspects: resistance to chloride ion permeability and inhibiting efficiency. The specimens with different mixing amount of sodium nitrite and migration corrosion inhibitors were used to verify the accuracy and reliability of this method. The results show the differences in inhibiting efficiency of the inhibitors clearly, indicating the reliability of this time-saving method.     

Oxidative photochemical decarboxylation of zaragozic acid A

A unique decomposition reaction of the novel squalene synthase inhibitors called zaragozic acids has been studied. Under very mild conditions, e.g. by merely exposing their solutions to air and visible light at ambient temperature, these compounds, characterized by the 2,8-dioxabicyclo[3.2.1]octane-4,6,7-trihydroxy-3,4,5-tricarboxylic acid core, rapidly decompose. As relatively stable intermediates in the cascade of decomposition, the biologically active 2,8-dioxabicyclo[3.2.1]octane-6,7-dihydroxy-4-keto-5-caroxylic acid (or 3,4-decarboxy-4-dehydro) derivatives of these compounds have been isolated in ca. 20% yield. Derivatization on the highly reactive 4-carbonyl group yields stable derivatives, several of which are potent inhibitors of squalene synthase. Further decomposition results in the elimination of C3 and C4 atoms and the carboxylic acid on C5, the oxidation of C5 to carboxylic acid and the liberation of the oxo group on C1. Specific results obtained with zaragozic acid A, a key representative of the family of these potent cholesterol-lowering agents, are presented in this study.     

2-苄基-5-羟基-4-氧戊酸叔丁酯的合成研究

以氯化2-苄基-5-重氮基-4-氧戊酸叔丁酯为原料,经过卤代反应、水解反应成功合成2-苄基-5-羟基-4-氧戊酸叔丁酯.对各步反应条件分别进行了分析和讨论.产品结构经1H-NMR和13C-NMR表征,总收率为74.4%.该方法制备α-羟基酮类化合物操作简单、成本低、收率高.     

天然气水合物新型动力学抑制剂抑制性能研究

提出了一种组合天然气水合物动力学抑制剂GHI1(聚乙烯吡略烷酮(Inhibex157)与二乙二醇丁醚按1:1的质量比组合而成).在温度为4℃、压力为8.5～9.0 MPa下的1.072 L反应釜内,采用定容法,通过反应引起的温度和压力变化,研究了GHI1对天然气水合物形成的抑制性能,比较了不添加抑制剂、添加商用抑制剂Inhibex501、添加GHI1以及Inhibex157后的水合物大量生成时的温度变化,并分析了添加Inhibex501和GHI1后水合物大量生成时的时间,探讨了组合抑制剂的抑制机理.研究结果表明:在天然气和水的反应体系中添加质量分数w为0.5%的GHI1后,天然气水合物生成的平均引导时间为4 800 min,不添加抑制剂几乎没有引导时间,添加w为0.5%的Inhibex501后,水合物生成的平均引导时间为2 100 min,只添加W为0.5%的Inhibex157,平均引导时间为650 min;机理分析认为GHI1中的Inhibex157主要阻止天然气分子进入水合物笼,而二乙二醇丁醚则阻止水分子进一步形成水合物笼.     

COX-2/DHODH双重抑制剂存在可行性的初步对接虚拟筛选研究

首次开展了探索环氧合酶-2(COX-2)和二氢乳清酸脱氢酶(DHODH)双重抑制剂存在的可行性研究工作。通过自建COX-2抑制剂数据库,采用虚拟筛选方法,以DHODH的晶体结构为靶标,对建的COX-2抑制剂数据库进行对接虚拟筛选,筛选出多个对DHODH可能有抑制作用并且具有COX-抑制活性的分子。研究表明,现有数据库中的25000系列、7000系列、26000系列以及33000系列的抑制剂最有可能成为DHODH和COX-2的双抑制剂,特别是其中的2500、7004和7006这三个抑制剂,具有进一步实验研究的价值。     

蛋白酪氨酸磷酸酶-1B抑制剂研究进展

 蛋白酪氨酸磷酸酶-1B(PTP-1B)在胰岛素信号转导中起负调节作用,是治疗2型糖尿病和肥胖症的一个新靶点。PTP-1B抑制剂可有效治疗2型糖尿病和肥胖症。本文综述了近年来PTP-1B抑制剂的研究进展,重点归纳了通过化学合成方法得到了多种PTP-1B抑制剂,如钒酸盐类化合物、磷酸酯类化合物、肽类化合物等。     

苦参中钠-葡萄糖协同转运蛋白2抑制活性成分的研究

对一个含400种中草药和民族药的组分库进行活性筛选,结果显示苦参的甲醇提取物具有良好的抑制钠-葡萄糖协同转运蛋白2（SGLT2）的活性.在生物活性导向的分离纯化策略下,运用中压柱色谱和半制备高效制备液相色谱对苦参甲醇提取物的活性成分进行分离纯化,根据理化性质和波谱数据鉴定所分离化合物的结构,并对所得到的化合物进行抑制SGLT2活性测试.从苦参的甲醇提取物中分离得到7个黄酮苷类化合物,鉴定为芒柄花素-7-O--D-吡喃木糖基-(16)--D-吡喃葡萄糖苷（1）、芒柄花素-7-O--D-呋喃芹糖基-(16)--D-吡喃葡萄糖苷（2）、三叶豆紫檀苷（3）、(-)-高丽槐素-3-O--D-吡喃半乳糖苷（4）、6-乙酰三叶豆紫檀苷（5）、罗思菌素（6）、芒柄花苷（7）.除化合物3外,其他化合物均为首次从苦参中分离得到.7个化合物均有抑制SGLT2的活性,其中具有高丽槐素苷元结构的苷类成分3～5具有较好的抑制SGLT2的活性,对SGLT2的抑制活性的IC50范围为2.61～4.47 mol/L.